DOLOXE

data insights

Key Feature

Clinical Trials Accelerators

Optimizes trial execution by benchmarking against successful studies, recommending protocol modifications, and reducing operational costs. It accelerates timelines, improves efficiency, and enhances trial success rates for sponsors, CROs, and clinical teams.

Request Demo →
Clinical Trials Accelerators

Key Features of Clinical Trials Accelerators Platform

1. Dynamic Trial Benchmarking

  • Comparative Analytics: Continuously compares ongoing trials against successful historical benchmarks across therapeutic areas.
  • Performance Indicators: Highlights trial design elements (enrollment speed, endpoint selection, site distribution) that correlate with higher success rates.
  • Risk Alerts: Flags protocol or operational risks early to prevent costly delays.

2. Protocol Optimization

  • AI-Powered Recommendations: Suggests modifications to trial protocols (eligibility criteria, dosing schedules, endpoint refinement) to improve efficiency.
  • Adaptive Design Guidance: Supports incorporation of modern trial designs (basket, umbrella, adaptive) to maximize data yield.
  • Regulatory Alignment: Ensures protocol adjustments remain compliant with FDA, EMA, and ICH guidelines.

3. Operational Efficiency & Cost Reduction

  • Timeline Acceleration: Identifies bottlenecks in site activation, patient recruitment, and data collection.
  • Resource Optimization: Recommends strategies to reduce trial costs (site selection, digital monitoring, decentralized trial tools).
  • Budget Impact Modeling: Forecasts savings from protocol modifications and operational streamlining.

4. Strategic Use Cases

  • Sponsors & CROs: Improve trial success rates and reduce operational overhead.
  • Clinical Teams: Gain actionable insights to refine trial design and execution.
  • Investors & Payers: Benefit from faster, more cost-efficient trials that accelerate patient access to therapies.

Benefits for Healthcare Players

Evidence-Based Efficiency:
  • Uses historical success data to guide real-time trial decisions.
Cost-Saving Impact:
  • Reduces trial expenditures while maintaining scientific rigor.
Accelerated Path to Market:
  • Shortens timelines, improving ROI and patient access.